CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 85 filers reported holding CYTOKINETICS INC in Q3 2014. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $963,000 | +19.8% | 66,447 | 0.0% | 0.00% | +33.3% |
| Q2 2017 | $804,000 | +222.9% | 66,447 | +243.1% | 0.00% | +200.0% |
| Q1 2017 | $249,000 | -1.6% | 19,367 | -6.9% | 0.00% | 0.0% |
| Q4 2016 | $253,000 | +25.2% | 20,798 | -5.6% | 0.00% | 0.0% |
| Q3 2016 | $202,000 | -3.3% | 22,032 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $209,000 | +34.8% | 22,032 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $155,000 | -34.0% | 22,032 | -2.0% | 0.00% | 0.0% |
| Q4 2015 | $235,000 | +61.0% | 22,493 | +3.3% | 0.00% | 0.0% |
| Q3 2015 | $146,000 | -77.4% | 21,778 | -77.3% | 0.00% | -66.7% |
| Q2 2015 | $646,000 | -28.1% | 96,128 | -27.5% | 0.00% | -25.0% |
| Q1 2015 | $899,000 | +314.3% | 132,667 | +389.0% | 0.00% | +300.0% |
| Q4 2014 | $217,000 | +128.4% | 27,128 | 0.0% | 0.00% | – |
| Q3 2014 | $95,000 | -25.2% | 27,128 | +1.8% | 0.00% | -100.0% |
| Q2 2014 | $127,000 | -44.5% | 26,657 | +10.6% | 0.00% | 0.0% |
| Q1 2014 | $229,000 | +69.6% | 24,105 | +16.2% | 0.00% | 0.0% |
| Q4 2013 | $135,000 | -16.1% | 20,745 | -2.2% | 0.00% | 0.0% |
| Q3 2013 | $161,000 | – | 21,207 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |